Physician profile
Darryl Lau
NPI 1801138060
$915,399.91
in general payments reported to CMS, 2019-2025
18 companies · $393K in 2025
The $393K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $48K · 2021: $9,992 · 2022: $158K · 2023: $145K · 2024: $160K · 2025: $393K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $400K · Royalty Or License: $167K · Grant: $49K · Travel and Lodging: $48K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $399,510.93 |
| Royalty Or License | $167,328.40 |
| Grant | $48,525.00 |
| Travel and Lodging | $47,886.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,875.00 |
| Food and Beverage | $11,856.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $250,689.31 | 2021-2025 | Other - Miscellaneous, Solus Alif, Safeop |
| Arteriocyte Medical Systems, INC. | $170,019.51 | 2023-2025 | Influx, Influx, Magellan |
| Stryker Corporation | $135,951.31 | 2020-2025 | Everest Spinal System, Cascadia Interbody System, Monterey Al |
| Cerapedics INC. | $115,404.12 | 2021-2023 | I-Factor Peptide Enhanced Bone Graft |
| Hyhte Holdings INC. | $80,248.55 | 2024-2025 | Masada |
| Nuvasive, INC. | $77,762.71 | 2020-2023 | Xlif, Tlif, Alif |
| Vb Spine LLC | $42,584.68 | 2025 | Cascadia Interbody System, Yukon Oct Spinal System, Es2 Spinal System |
| Medtronic, INC. | $27,773.62 | 2022-2025 | Unid_pass, Mazor X System, Stealthstation S8 Platform |
| Viseon, INC. | $12,393.36 | 2022-2025 | Maxview System - Lateral Set |
| Globus Medical, INC. | $1,206.38 | 2020 | |
| Orthofix Medical, INC. | $451.24 | 2022-2025 | Cervical-Stim, Spinal-Stim |
| Medtronic USA, INC. | $327.50 | 2019-2020 | |
| Medical Device Business Services, INC. | $206.16 | 2024 | Conduit |
| Depuy Synthes Sales INC. | $132.38 | 2021-2023 | Conduit, Viper, Vivigen Mis Delivery System |
| Djo, LLC | $112.50 | 2023 | Cmf |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ebi, LLC | $60.62 | 2025 | |
| Highridge Medical LLC | $60.62 | 2025 | Spine-None |
| Carbofix Spine INC | $15.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.